Liotta LA - Search Results

1

RPPA: Origins, Transition to a Validated Clinical Research Tool, and Next Generations of the Technology.

Petricoin E 3rd, Wulfkuhle J, Howard M, Pierobon M, Espina V, Luchini A, Liotta LA. Petricoin E 3rd, et al. Among authors: liotta la. Adv Exp Med Biol. 2019;1188:1-19. doi: 10.1007/978-981-32-9755-5_1. Adv Exp Med Biol. 2019. PMID: 31820380

2

Reverse phase protein microarrays advance to use in clinical trials.

Mueller C, Liotta LA, Espina V. Mueller C, et al. Among authors: liotta la. Mol Oncol. 2010 Dec;4(6):461-81. doi: 10.1016/j.molonc.2010.09.003. Epub 2010 Oct 16. Mol Oncol. 2010. PMID: 20974554 Free PMC article. Review.

3

Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays.

Wulfkuhle JD, Edmiston KH, Liotta LA, Petricoin EF 3rd. Wulfkuhle JD, et al. Among authors: liotta la. Nat Clin Pract Oncol. 2006 May;3(5):256-68. doi: 10.1038/ncponc0485. Nat Clin Pract Oncol. 2006. PMID: 16683004 Review.

4

Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.

VanMeter A, Signore M, Pierobon M, Espina V, Liotta LA, Petricoin EF 3rd. VanMeter A, et al. Among authors: liotta la. Expert Rev Mol Diagn. 2007 Sep;7(5):625-33. doi: 10.1586/14737159.7.5.625. Expert Rev Mol Diagn. 2007. PMID: 17892368 Review.

5

Reverse phase protein microarrays for monitoring biological responses.

Espina V, Wulfkuhle JD, Calvert VS, Petricoin EF 3rd, Liotta LA. Espina V, et al. Among authors: liotta la. Methods Mol Biol. 2007;383:321-36. doi: 10.1007/978-1-59745-335-6_21. Methods Mol Biol. 2007. PMID: 18217695

6

Molecular network analysis using reverse phase protein microarrays for patient tailored therapy.

Speer R, Wulfkuhle J, Espina V, Aurajo R, Edmiston KH, Liotta LA, Petricoin EF 3rd. Speer R, et al. Among authors: liotta la. Adv Exp Med Biol. 2008;610:177-86. doi: 10.1007/978-0-387-73898-7_13. Adv Exp Med Biol. 2008. PMID: 18593023 Review. No abstract available.

7

Reverse-phase protein microarrays for theranostics and patient tailored therapy.

Espina V, Liotta LA, Petricoin EF 3rd. Espina V, et al. Among authors: liotta la. Methods Mol Biol. 2009;520:89-105. doi: 10.1007/978-1-60327-811-9_7. Methods Mol Biol. 2009. PMID: 19381949

8

Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment.

Espina V, Wulfkuhle J, Liotta LA. Espina V, et al. Among authors: liotta la. Clin Lab Med. 2009 Mar;29(1):1-13. doi: 10.1016/j.cll.2009.03.001. Clin Lab Med. 2009. PMID: 19389547 Review.

9

Monitoring proteins and protein networks using reverse phase protein arrays.

Wilson B, Liotta LA, Petricoin E 3rd. Wilson B, et al. Among authors: liotta la. Dis Markers. 2010;28(4):225-32. doi: 10.3233/DMA-2010-0705. Dis Markers. 2010. PMID: 20534907 Free PMC article. Review.

10

A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum.

Longo C, Gambara G, Espina V, Luchini A, Bishop B, Patanarut AS, Petricoin EF 3rd, Beretti F, Ferrari B, Garaci E, De Pol A, Pellacani G, Liotta LA. Longo C, et al. Among authors: liotta la. Exp Dermatol. 2011 Jan;20(1):29-34. doi: 10.1111/j.1600-0625.2010.01187.x. Exp Dermatol. 2011. PMID: 21158936 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

691 results

Search Page

Filters